We focused our study on sFTD, negative for the presence of disease-causing mutations in GRN, MAPT and C9orf72. Since genetic factors have a substantially higher pathogenetic contribution in early onset patients than in late onset dementia, we selected patients with disease onset before 65 years of age. Here, MAPT is linked to dementia.